CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2007-12-13): Merck recalls 1.2 mln doses of children's vaccines

Regulatory

Merck recalls 1.2 mln doses of children's vaccines

Last Updated: 2007-12-13 16:53:50 -0400 (Reuters Health)

WASHINGTON (Reuters) - Merck & Co Inc on Wednesday voluntarily recalled about 1.2 million doses of its widely used children's vaccines after quality-control checks found production equipment may not have been properly sterilized.

The vaccines protect against Hib disease (Haemophilus influenzae type b), which was the leading cause of bacterial meningitis in children less than 5 years old, according to the U.S. Centers for Disease Control and Prevention.

Merck said it recalled 11 lots of PedvaxHIB vaccine and two lots of its Comvax vaccine due to lack of assurance of product sterility. Both of the recalled vaccines protect against Hib and other conditions. Comvax also prevents hepatitis B.

The vaccines were manufactured in West Point, Pennsylvania, and distributed starting in April 2007. All but one lot was distributed in the United States, the company said.

"The potential for contamination of any individual vaccine is low, and, if present, the level of contamination would be low," Merck said.

Sterility tests of the vaccine lots subjected to recall did not turn up any contamination, said Merck, which added that the recall does not affect any other vaccines it manufactures.

Children who have received the affected vaccine do not need to be revaccinated because efficacy was not compromised, said Dr. Anne Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases.

She advised parents to look for signs of infection at the site of the inoculation in the days following the injection.

"After a week, you would definitely be out of the woods," Schuchat said.

Before vaccination became common, Hib struck one child out of every 200 in that age group, causing permanent brain damage in a quarter and killing 1 in 20.

The CDC has recommended that children receive Hib vaccine for nearly a decade. Fewer than 100 documented Hib cases currently are reported in the United States each year.

Health officials said they have urged Sanofi Pasteur, Sanofi-Aventis' vaccine business, to boost supplies in a bid to fill the gap caused by the recall.

The United States requires about 14 million doses annually to fully vaccinate babies and toddlers, and officials said they planned to tap vaccine stockpiles to help meet the need.

"We do expect there to be a shortage. The extent of that we're trying to find out," said the CDC's Schuchat. She added that the recall does not pose an immediate health risk because more than 90 percent of U.S. children have received the vaccine.

"We have a cushion of protection as we go into the recall," Schuchat said.

In November, Merck agreed to pay $4.85 billion to settle most claims that Vioxx, its withdrawn painkiller, caused heart attacks and strokes in thousands of users.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.